JPH037670B2 - - Google Patents

Info

Publication number
JPH037670B2
JPH037670B2 JP56211626A JP21162681A JPH037670B2 JP H037670 B2 JPH037670 B2 JP H037670B2 JP 56211626 A JP56211626 A JP 56211626A JP 21162681 A JP21162681 A JP 21162681A JP H037670 B2 JPH037670 B2 JP H037670B2
Authority
JP
Japan
Prior art keywords
carbon atoms
group
alkyl group
lower alkyl
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP56211626A
Other languages
English (en)
Japanese (ja)
Other versions
JPS58116466A (ja
Inventor
Masaaki Hamada
Kaoru Okamoto
Teikichi Kurosaki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nippon Zoki Pharmaceutical Co Ltd
Original Assignee
Nippon Zoki Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Zoki Pharmaceutical Co Ltd filed Critical Nippon Zoki Pharmaceutical Co Ltd
Priority to JP56211626A priority Critical patent/JPS58116466A/ja
Priority to AU91813/82A priority patent/AU559732B2/en
Priority to US06/452,146 priority patent/US4555513A/en
Priority to EP82306916A priority patent/EP0083222B1/en
Priority to AT82306916T priority patent/ATE18211T1/de
Priority to DE8282306916T priority patent/DE3269533D1/de
Priority to DK569082A priority patent/DK569082A/da
Priority to CA000418496A priority patent/CA1192198A/en
Priority to KR1019820005817A priority patent/KR840002813A/ko
Priority to ES518613A priority patent/ES518613A0/es
Publication of JPS58116466A publication Critical patent/JPS58116466A/ja
Publication of JPH037670B2 publication Critical patent/JPH037670B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/233—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/04—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms
    • C07D215/06—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms having only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/04—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms
    • C07D215/08—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms with acylated ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/18—Halogen atoms or nitro radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
JP56211626A 1981-12-29 1981-12-29 新規キノリル酢酸誘導体及び該化合物を含有する医薬組成物 Granted JPS58116466A (ja)

Priority Applications (10)

Application Number Priority Date Filing Date Title
JP56211626A JPS58116466A (ja) 1981-12-29 1981-12-29 新規キノリル酢酸誘導体及び該化合物を含有する医薬組成物
AU91813/82A AU559732B2 (en) 1981-12-29 1982-12-22 Di-and-tetrahydroguinolylacetic acid esters
US06/452,146 US4555513A (en) 1981-12-29 1982-12-22 1,2 Dihydro- and 1,2,3,4-tetrahydro quinolylacetic acids and analgesic use thereof
EP82306916A EP0083222B1 (en) 1981-12-29 1982-12-23 New quinolylacetic acid compounds and pharmaceutical compositions containing them
AT82306916T ATE18211T1 (de) 1981-12-29 1982-12-23 Chinolinessigsaeuren und diese enthaltende pharmazeutische zubereitungen.
DE8282306916T DE3269533D1 (en) 1981-12-29 1982-12-23 New quinolylacetic acid compounds and pharmaceutical compositions containing them
DK569082A DK569082A (da) 1981-12-29 1982-12-23 Quinolyleddikesyreforbindelser og pharmaceutiske blandinger indeholdende disse forbindelser
CA000418496A CA1192198A (en) 1981-12-29 1982-12-23 Quinolylacetic acid compounds, process for producing thereof and pharmaceutical compositions containing them
KR1019820005817A KR840002813A (ko) 1981-12-29 1982-12-27 신규 퀴놀린 초산 유도체의 제조법
ES518613A ES518613A0 (es) 1981-12-29 1982-12-28 Un procedimiento para preparar compuestos de acido quinolilacetico

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP56211626A JPS58116466A (ja) 1981-12-29 1981-12-29 新規キノリル酢酸誘導体及び該化合物を含有する医薬組成物

Publications (2)

Publication Number Publication Date
JPS58116466A JPS58116466A (ja) 1983-07-11
JPH037670B2 true JPH037670B2 (en]) 1991-02-04

Family

ID=16608881

Family Applications (1)

Application Number Title Priority Date Filing Date
JP56211626A Granted JPS58116466A (ja) 1981-12-29 1981-12-29 新規キノリル酢酸誘導体及び該化合物を含有する医薬組成物

Country Status (10)

Country Link
US (1) US4555513A (en])
EP (1) EP0083222B1 (en])
JP (1) JPS58116466A (en])
KR (1) KR840002813A (en])
AT (1) ATE18211T1 (en])
AU (1) AU559732B2 (en])
CA (1) CA1192198A (en])
DE (1) DE3269533D1 (en])
DK (1) DK569082A (en])
ES (1) ES518613A0 (en])

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0317061A (ja) * 1989-06-13 1991-01-25 Kyorin Pharmaceut Co Ltd 新規環状アントラニル酸酢酸誘導体
JP3209568B2 (ja) * 1991-04-16 2001-09-17 杏林製薬株式会社 新規環状アミノフェニル酢酸誘導体、その製造法及びそれらを有効成分とする免疫応答の修飾剤
US5666014A (en) * 1994-07-20 1997-09-09 Mechanical Technology Inc. Velocity-controlled magnetic bearings
US5776482A (en) * 1996-03-29 1998-07-07 University Of Iowa Research Foundation Tetrahydroquinoline analogues for use in glaucoma treatment
GB9818641D0 (en) * 1998-08-26 1998-10-21 Rh Ne Poulenc Rorer Limited Chemical compounds
WO2006046915A1 (en) * 2004-10-29 2006-05-04 Astrazeneca Ab Use of unsaturated quionoline or naphtalene derivatives as medicaments

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2042352A1 (fr) * 1969-04-21 1971-02-12 Ciba Geigy Ag Acides alpha-(1,2,3,4-tetrahydro-6-quinolyl)-carboxyliques et leurs derives
CH578533A5 (en]) * 1972-03-10 1976-08-13 Ciba Geigy Ag
FR2278338A1 (fr) * 1974-07-15 1976-02-13 Bouchara Emile Derives de la dihydro-1-2 trimethyl-2-2-4 quinoleine et application comme medicaments
CH628892A5 (it) * 1977-06-22 1982-03-31 Simes Procedimento per la preparazione di acidi chinolinici ad attivita antiinfiammatoria.
JPS54128584A (en) * 1978-03-28 1979-10-05 Teijin Ltd Novel 3,4-dihydrocarbostyril derivative

Also Published As

Publication number Publication date
ES8406442A1 (es) 1984-08-01
ATE18211T1 (de) 1986-03-15
EP0083222A1 (en) 1983-07-06
DE3269533D1 (en) 1986-04-03
DK569082A (da) 1983-06-30
AU559732B2 (en) 1987-03-19
AU9181382A (en) 1983-07-07
ES518613A0 (es) 1984-08-01
EP0083222B1 (en) 1986-02-26
JPS58116466A (ja) 1983-07-11
US4555513A (en) 1985-11-26
KR840002813A (ko) 1984-07-21
CA1192198A (en) 1985-08-20

Similar Documents

Publication Publication Date Title
JP3775796B2 (ja) 抗炎症活性及び／又は鎮痛活性を有する硝酸エステル類及びそれらの製造方法
DE2705446C2 (en])
US5847128A (en) Water soluble derivatives of cannabinoids
JPS6253504B2 (en])
PL175265B1 (pl) Nowa pochodna arylopropionowa sól trometaminowa kwasu (+)-S-2-(3-benzoilofenylo)propionowego, sposób jej wytwarzania i kompozycja farmaceutyczna
US3957850A (en) Phenylacetic acid derivatives
CS267551B1 (en) Pharmaceutical agents for asthma treatment and method of effective substance production
US5288750A (en) Substituted β-diketones
JPH059424B2 (en])
EP0024960B1 (fr) Nouvelles phénoxyamines hétérocycliques substituées, procédé pour leur préparation et leur application comme anesthésiques locaux
US4423056A (en) 5(Aminomethyl)-4,5,6,7-tetrahydro[d]thiazole containing compositions for and medical use in treating circulatory insufficiencies
EP0239461A1 (fr) Dérivés de N-¬¬(hydroxy-2 phényl) (phényl) méthylène amino-2 éthyl acétamide, leur préparation et leur application en thérapeutique
JPH037670B2 (en])
EP0005559B1 (de) Phenylaminothiophenessigsäuren, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel
JPH0234951B2 (en])
DD283602A5 (de) Verfahren zur herstellung von verbindungen und deren verwendung
FR2567520A1 (fr) Nouvelles phenyl-naphthyridines, leur procede de preparation, medicaments les contenant, notamment anti-ulceres
CA1139763A (fr) Procede d'obtention de nouveaux aryltrifluoroethanols
PT100216B (pt) N-{{4,5-di-hidroxi- e 4,5,8-tri-hidroxi-9,10-di-hidro-9,10-dioxo-2-antracentil} carbonil}-aminoacidos uteis na terapia de afeccoes osteoarticulares, processo para a sua preparacao e composicoes farmaceuticas que os contem
US4285935A (en) Dehydropeptide compounds, their production and their medical use
JPS6124388B2 (en])
US4219668A (en) 4-Hydroxy,4-biphenylbutyric acid
HU201082B (en) Enolethers of 6-chloro-4-hydroxy-2-methyl-N-(2-pyridyl)-2H-thieno(2,3-e)-1,2-thiazin-3-carboxylic acid amide-1,1-dioxide, a process for their preparation and their use.
JPH0692948A (ja) 新規なアセタミド誘導体及びその用途
US3056792A (en) Unsymmetrical 1, 3-diamino-2-propanols